Please login to the form below
virtual trials
This page shows the latest virtual trials news and features for those working in and with pharma, biotech and healthcare.
Novartis pushes ‘virtual’ clinical trial concept
process. The aim is to expand the number of ‘virtual’trials it runs, with patients interacting with investigators via mobile phones and telemedicine devices rather than attending investigation sites in person. ... It’s already running semi-virtual
Latest news
-
PatientsLikeMe launches 'virtual trial' in ALS
to eliminate many of the frustrations patients say are inherent in traditional clinical trials. “ ... Attempts to pursue virtual trials within pharma have had mixed success to date, with Pfizer's pioneering efforts in managing study participation
-
inVentiv invests in virtual trials
inVentiv invests in virtual trials. Acquires equity stake in US-based Mytrus. ... Contract research organisation (CRO) inVentiv Health Clinical has acquired an equity stake in US-based 'virtual clinical trials' firm Mytrus.
-
Pilot study combines patient-reported outcomes and medical records
As direct-to-patient observational studies grow in number and size, experience and insights from these designs can be considered for integration into interventional clinical trials,” the researchers wrote in the
-
Pfizer: we won’t abandon social media in trials because virtual study failed
Pfizer: we won’ t abandon social media in trials because virtual study failed. ... Pfizer has vowed to continue to use social media and the internet to boost patient recruitment rates in its clinical trials despite the failure of a 'virtual' study pilot
-
Pfizer: we won’t abandon social media in trials because virtual study failed
Pfizer: we won’ t abandon social media in trials because virtual study failed. ... Pfizer has vowed to continue to use social media and the internet to boost patient recruitment rates in its clinical trials despite the failure of a 'virtual' study pilot
More from news
Approximately 2 fully matching, plus 6 partially matching documents found.
Latest Intelligence
-
A new era of smart pharma
Transforming the approach to drug development. Recruitment of subjects plus their management and monitoring within trials is challenging and several organisations have tried to conduct ‘virtual trials’with limited success. ... Clearly protocol
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Account Manager
-
Negotiable
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Senior Writer, Healthcare Advertising, London
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Account Director or Senior Account Director
-
Salary TBC
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
-
Systematic Review Lead- London
-
Negotiable
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
Subscribe to our email news alerts
- Moving annual total (MAT)
- AZ prepares to file COPD triple, taking on rival GSK
- J&J files ‘breakthrough’ bladder cancer drug in US
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Teva wins FDA OK for crucial migraine drug
- NHS wins legal fight with pharma over off-label Avastin
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
- Bayer roll-out of haemophilia drug Jivi gathers pace
PMHub
Wordbird
Wordbird is a healthcare communications agency with creative, compelling copy at its heart....
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
